The Kraft Heinz Company global nutrition targets for the innovation and reformulation of food and beverages: Current and future directions

Reformulating packaged foods has the potential to improve the nutrient density of the global diet. The present perspective illustrates The Kraft Heinz Company’s approach to product (re)formulation to develop healthier product lines that are lower in saturated fats, total sugars, and sodium, and contain health promoting components. Here we present the rationale for The Kraft Heinz Company’s global nutrition targets used for the global innovation and renovation of foods and beverages. The global nutrition targets use a category specific approach to set maximum levels for the main nutrients of public health concern: saturated fat, total sugars and sodium, taking into account product characteristics (typical portion size, eating occasion, role in the diet, etc.) as well as regulatory, technological, sensory and safety constraints. Benchmarking examples illustrate how the nutrition targets are positioned within the United States, France, and Australia. These global nutrition targets serve as part of The Kraft Heinz Company’s environmental, social and governance nutrition commitments and demonstrates how the food industry is improving the nutritional value of packaged foods and beverages both now and into the future

Australian consumers are willing to pay for the health star rating front-of-pack nutrition label

© 2020 by the authors. Licensee MDPI, Basel, Switzerland. The Australia and New Zealand Ministerial Forum on Food Regulation has supported the recommendations set out in the 2019 Health Star Rating System Five Year Review Report. Specifically, the forum supported, in principle, Recommendation 9, to mandate the Health Star Rating if clear uptake targets were not achieved while the system is voluntary. Given that mandatory labelling is being considered, it is important to investigate how much consumers value the Health Star Rating in order to understand potential consumer uptake and inform industry. The aim of this study was to assess consumers’ valuation of the Health Star Rating system by analysing their willingness to pay for a packaged food product with the Health Star Rating label, utilising a double-bounded dichotomous choice contingent valuation approach. The results indicate that almost two-thirds of Australian household grocery shoppers were willing to pay more for a product with the Health Star Rating, on average up to an additional 3.7% of the price of the product. However, public health nutrition benefits associated with consumers’ willingness to pay more for products with the Health Star Rating is currently limited by the lack of guarantee of the systems’ accuracy. Given consumer support, a well validated and comprehensive Health Star Rating labelling system can potentially improve health outcomes, cost effectiveness and reduce environmental impacts

Eff ect of Revalor- XH, Revalor- 200, and Combination Revalor- IH/Revalor- 200 on Yearling Heifer Growth Performance and Carcass Characteristics

A commercial feedlot trial tested three implant strategies (Revalor- 200 on day 0, Revalor- IH on d 0 and re- implanted with Revalor- 200 on d 56, or Revalor- XH on d 0) on growth performance and carcass characteristics of heifers fed for 138 d. Th ere were no differences observed for final body weight, dry matter intake, or average daily gain on a live basis among implant strategies. Heifers implanted with Revalor- IH/200 combination had greater carcass- adjusted final body weight and improved feed conversion compared to Revalor- 200 and Revalor- XH. Hot carcass weights, dressing percent, and LM area were improved for Revalor- IH/200 implanted heifers relative to Revalor- 200 and Revalor- XH implanted heifers. Marbling score and 12th- rib fat thickness were not different among implant treatments. Heifers implanted with Revalor- IH/200 had a shift to a lower USDA yield grade distribution compared to 200 and XH implanted heifers. Th e greater concentration of trenbolone acetate and estradiol provided by Revalor- IH/200 combination slightly improved growth and carcass performance compared to the non- coated Revalor- 200 implant and partially coated Revalor- XH implant

A Comparison of Synovex ONE® Alone to Synovex Choice® Followed by Synovex Plus® as Implant Strategies for Finishing Heifers

A commercial feedlot study utilizing 1,737 crossbred heifers (initial BW 690 lb) compared the effect of two implant strategies [Synovex ONE Feedlot (day 0) or Synovex Choice (day 0) followed by Synovex Plus (day 95)] on performance and carcass characteristics. No differences were observed in carcass weight, final body weight, or gain, but heifers implanted with Synovex ONE Feedlot had slightly greater feed conversion and greater intake than heifers implanted using Synovex Choice/Synovex Plus. Heifers implanted with Synovex Choice/Synovex Plus had lower marbling score and yield grade, higher dressing percentage, and greater loin muscle area compared to heifers implanted with Synovex ONE Feedlot. Cattle implanted with Synovex ONE Feedlot showed a tendency for better quality grading compared to heifers implanted with Synovex Choice/Synovex Plus. These data suggest that implanting heifers with Synovex ONE Feedlot gives comparable growth to heifers implanted with Synovex Choice followed by Synovex Plus, with some changes in fatness when fed equal days

Depression and HIV in Botswana: A Population-Based Study on Gender-Specific Socioeconomic and Behavioral Correlates

Depression is a leading contributor to the burden of disease worldwide, a critical barrier to HIV prevention and a common serious HIV co-morbidity. However, depression screening and treatment are limited in sub-Saharan Africa, and there are few population-level studies examining the prevalence and gender-specific factors associated with depression.We conducted a cross-sectional population-based study of 18–49 year-old adults from five districts in Botswana with the highest prevalence of HIV-infection. We examined the prevalence of depressive symptoms, using a Hopkins Symptom Checklist for Depression (HSCL-D) score of ≥1.75 to define depression, and correlates of depression using multivariate logistic regression stratified by sex.Of 1,268 participants surveyed, 25.3% of women and 31.4% of men had depression. Among women, lower education (adjusted odds ratio [AOR] 2.07, 95% confidence interval [1.30–3.32]), higher income (1.77 [1.09–2.86]), and lack of control in sexual decision-making (2.35 [1.46–3.81]) were positively associated with depression. Among men, being single (1.95 [1.02–3.74]), living in a rural area (1.63 [1.02–2.65]), having frequent visits to a health provider (3.29 [1.88–5.74]), anticipated HIV stigma (fearing discrimination if HIV status was revealed) (2.04 [1.27–3.29]), and intergenerational sex (2.28 [1.17–4.41]) were independently associated with depression.Depression is highly prevalent in Botswana, and its correlates are gender-specific. Our findings suggest multiple targets for screening and prevention of depression and highlight the need to integrate mental health counseling and treatment into primary health care to decrease morbidity and improve HIV management efforts

Finishing the euchromatic sequence of the human genome

The sequence of the human genome encodes the genetic instructions for human physiology, as well as rich information about human evolution. In 2001, the International Human Genome Sequencing Consortium reported a draft sequence of the euchromatic portion of the human genome. Since then, the international collaboration has worked to convert this draft into a genome sequence with high accuracy and nearly complete coverage. Here, we report the result of this finishing process. The current genome sequence (Build 35) contains 2.85 billion nucleotides interrupted by only 341 gaps. It covers ∼99% of the euchromatic genome and is accurate to an error rate of ∼1 event per 100,000 bases. Many of the remaining euchromatic gaps are associated with segmental duplications and will require focused work with new methods. The near-complete sequence, the first for a vertebrate, greatly improves the precision of biological analyses of the human genome including studies of gene number, birth and death. Notably, the human enome seems to encode only 20,000-25,000 protein-coding genes. The genome sequence reported here should serve as a firm foundation for biomedical research in the decades ahead

Eff ect of Revalor- XH, Revalor- 200, and Combination Revalor- IH/Revalor- 200 on Yearling Heifer Growth Performance and Carcass Characteristics

A commercial feedlot trial tested three implant strategies (Revalor- 200 on day 0, Revalor- IH on d 0 and re- implanted with Revalor- 200 on d 56, or Revalor- XH on d 0) on growth performance and carcass characteristics of heifers fed for 138 d. Th ere were no differences observed for final body weight, dry matter intake, or average daily gain on a live basis among implant strategies. Heifers implanted with Revalor- IH/200 combination had greater carcass- adjusted final body weight and improved feed conversion compared to Revalor- 200 and Revalor- XH. Hot carcass weights, dressing percent, and LM area were improved for Revalor- IH/200 implanted heifers relative to Revalor- 200 and Revalor- XH implanted heifers. Marbling score and 12th- rib fat thickness were not different among implant treatments. Heifers implanted with Revalor- IH/200 had a shift to a lower USDA yield grade distribution compared to 200 and XH implanted heifers. Th e greater concentration of trenbolone acetate and estradiol provided by Revalor- IH/200 combination slightly improved growth and carcass performance compared to the non- coated Revalor- 200 implant and partially coated Revalor- XH implant

Dietitians\u27 perceptions of the healthiness of packaged food

The aim of this cross-sectional study was to determine the factors that influence Australian dietitians\u27 perceptions of the healthiness of a sample of packaged foods. Participant dietitians (n = 120) rated the healthiness (1, less healthy to 10, more healthy), of seven packaged foods (bread, confectionary, breakfast cereal, flavoured yoghurt, curry, spread and crumble) based on information obtained from an ingredient list and nutrient information panel (NIP). Influences on each food\u27s rating were explored via Likert-scale and open-response questions. There was variation in the healthiness rating of all foods, however, least so for confectionary and crumble. Bread (M = 7.39 ± 1.44) and confectionary (M = 1.33 ± 0.69) were rated the most and least healthy foods respectively. Crumble was rated significantly (p = 0.03) healthier by those with more experience (≥6 vs. ≤5 years). No other differences were detected. Highly reported influences on healthiness were sugar, total fat, sodium and saturated fat values and the ingredient list. Content analysis identified 13 categories of information not provided on the NIP that influenced participants\u27 ratings. References to the Australian Guide to Healthy Eating food groups, micronutrients not listed as ingredients, comparisons to other foods, and fibre were most common among the sample. These results have implications for research or public health policy where expert opinion of the healthiness of food is used as a reference measure

Construct and criterion-related validation of nutrient profiling models: a systematic review of the literature

Nutrient profiling (NP) is defined as the science of ranking foods according to their nutritional composition for the purpose of preventing disease or promoting health. The application of NP is ultimately to assist consumers to make healthier food choices, and thus provide a cost effective public health strategy to reduce the incidence of diet-related chronic disease. To our knowledge, no review has assessed the evidence to confirm the validity of NP models. We conducted a systematic review to investigate the construct and criterion-related validity of NP models in ranking food according to their nutritional composition for the purpose of preventing disease and promoting health. We searched peer-reviewed research published to 30 June 2015 and used PUBMED, Global Health (CABI), and SCOPUS databases. Within study bias was assessed using an adapted version of the QUADAS-2 (Quality Assessment of Diagnostic Accuracy Studies -2) tool for all diagnostic studies and the Cochrane Collaboration’s Risk of Bias tool for all non-diagnostic studies. The GRADE (Grades of Recommendation, Assessment, Development, and Evaluation) approach was used to guide our judgement of the quality of the body of evidence for each outcome measure. From a total of 83 studies, 69 confirmed the construct validity of NP models; however most of these studies contained methodological weaknesses. Six studies used objective external measures to confirm the criterion-related validity of NP models; which inherently improved quality. The overall quality of evidence on the accuracy of NP models was judged to be very low to moderate using the GRADE approach. Many carefully designed studies to establish both construct and criterion-related validity are necessary to authenticate the application of NP models and provide the evidence to support the current definition of NP